Cargando…
A novel One-pot rapid diagnostic technology for COVID-19
Novel coronavirus disease (COVID-19) caused by SARS-CoV-2 is an ongoing global pandemic associated with high rates of morbidity and mortality. RT-qPCR has become the diagnostic standard for the testing of SARS-CoV-2 in most countries. COVID-19 diagnosis generally relies upon RT-qPCR-mediated identif...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877206/ https://www.ncbi.nlm.nih.gov/pubmed/33736798 http://dx.doi.org/10.1016/j.aca.2021.338310 |
_version_ | 1783650121343303680 |
---|---|
author | Li, Junmin Hu, Xuejiao Wang, Xiaoming Yang, Jianing Zhang, Lei Deng, Qianyun Zhang, Xiqin Wang, Zixia Hou, Tieying Li, Shan |
author_facet | Li, Junmin Hu, Xuejiao Wang, Xiaoming Yang, Jianing Zhang, Lei Deng, Qianyun Zhang, Xiqin Wang, Zixia Hou, Tieying Li, Shan |
author_sort | Li, Junmin |
collection | PubMed |
description | Novel coronavirus disease (COVID-19) caused by SARS-CoV-2 is an ongoing global pandemic associated with high rates of morbidity and mortality. RT-qPCR has become the diagnostic standard for the testing of SARS-CoV-2 in most countries. COVID-19 diagnosis generally relies upon RT-qPCR-mediated identification of SARS-CoV-2 viral RNA, which is costly, labor-extensive, and requires specialized training and equipment. Herein, we established a novel one-tube rapid diagnostic approach based upon formamide and colorimetric RT-LAMP (One-Pot RT-LAMP) that can be used to diagnose COVID-19 without the extraction of specific viral RNA. The technique could visually detect SARS-CoV-2 within 45 min with a limit of detection of 5 copies per reaction in extracted RNA, and about 7.66 virus copies per μL in viral transport medium. The One-Pot RT-LAMP test showed a high specificity without cross-reactivity with 12 viruses including SARS-CoV, MERS-CoV, and human infectious influenza virus (H1N1/H3N2 of influenza A and B virus, ect. We validated this One-Pot RT-LAMP approach by its successful use for the analysis of 45 clinical nasopharyngeal swab samples, yielding results identical to those of traditional RT-qPCR analyses, while achieving good selectivity and sensitivity relative to a commercial RT-qPCR approach. As such, this One-Pot RT-LAMP technology may be a valid means of conducting high-sensitivity, low-cost and rapid SARS-CoV-2 identification without the extraction of viral RNA. |
format | Online Article Text |
id | pubmed-7877206 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78772062021-02-11 A novel One-pot rapid diagnostic technology for COVID-19 Li, Junmin Hu, Xuejiao Wang, Xiaoming Yang, Jianing Zhang, Lei Deng, Qianyun Zhang, Xiqin Wang, Zixia Hou, Tieying Li, Shan Anal Chim Acta Article Novel coronavirus disease (COVID-19) caused by SARS-CoV-2 is an ongoing global pandemic associated with high rates of morbidity and mortality. RT-qPCR has become the diagnostic standard for the testing of SARS-CoV-2 in most countries. COVID-19 diagnosis generally relies upon RT-qPCR-mediated identification of SARS-CoV-2 viral RNA, which is costly, labor-extensive, and requires specialized training and equipment. Herein, we established a novel one-tube rapid diagnostic approach based upon formamide and colorimetric RT-LAMP (One-Pot RT-LAMP) that can be used to diagnose COVID-19 without the extraction of specific viral RNA. The technique could visually detect SARS-CoV-2 within 45 min with a limit of detection of 5 copies per reaction in extracted RNA, and about 7.66 virus copies per μL in viral transport medium. The One-Pot RT-LAMP test showed a high specificity without cross-reactivity with 12 viruses including SARS-CoV, MERS-CoV, and human infectious influenza virus (H1N1/H3N2 of influenza A and B virus, ect. We validated this One-Pot RT-LAMP approach by its successful use for the analysis of 45 clinical nasopharyngeal swab samples, yielding results identical to those of traditional RT-qPCR analyses, while achieving good selectivity and sensitivity relative to a commercial RT-qPCR approach. As such, this One-Pot RT-LAMP technology may be a valid means of conducting high-sensitivity, low-cost and rapid SARS-CoV-2 identification without the extraction of viral RNA. Elsevier B.V. 2021-04-15 2021-02-11 /pmc/articles/PMC7877206/ /pubmed/33736798 http://dx.doi.org/10.1016/j.aca.2021.338310 Text en © 2021 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Li, Junmin Hu, Xuejiao Wang, Xiaoming Yang, Jianing Zhang, Lei Deng, Qianyun Zhang, Xiqin Wang, Zixia Hou, Tieying Li, Shan A novel One-pot rapid diagnostic technology for COVID-19 |
title | A novel One-pot rapid diagnostic technology for COVID-19 |
title_full | A novel One-pot rapid diagnostic technology for COVID-19 |
title_fullStr | A novel One-pot rapid diagnostic technology for COVID-19 |
title_full_unstemmed | A novel One-pot rapid diagnostic technology for COVID-19 |
title_short | A novel One-pot rapid diagnostic technology for COVID-19 |
title_sort | novel one-pot rapid diagnostic technology for covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7877206/ https://www.ncbi.nlm.nih.gov/pubmed/33736798 http://dx.doi.org/10.1016/j.aca.2021.338310 |
work_keys_str_mv | AT lijunmin anovelonepotrapiddiagnostictechnologyforcovid19 AT huxuejiao anovelonepotrapiddiagnostictechnologyforcovid19 AT wangxiaoming anovelonepotrapiddiagnostictechnologyforcovid19 AT yangjianing anovelonepotrapiddiagnostictechnologyforcovid19 AT zhanglei anovelonepotrapiddiagnostictechnologyforcovid19 AT dengqianyun anovelonepotrapiddiagnostictechnologyforcovid19 AT zhangxiqin anovelonepotrapiddiagnostictechnologyforcovid19 AT wangzixia anovelonepotrapiddiagnostictechnologyforcovid19 AT houtieying anovelonepotrapiddiagnostictechnologyforcovid19 AT lishan anovelonepotrapiddiagnostictechnologyforcovid19 AT lijunmin novelonepotrapiddiagnostictechnologyforcovid19 AT huxuejiao novelonepotrapiddiagnostictechnologyforcovid19 AT wangxiaoming novelonepotrapiddiagnostictechnologyforcovid19 AT yangjianing novelonepotrapiddiagnostictechnologyforcovid19 AT zhanglei novelonepotrapiddiagnostictechnologyforcovid19 AT dengqianyun novelonepotrapiddiagnostictechnologyforcovid19 AT zhangxiqin novelonepotrapiddiagnostictechnologyforcovid19 AT wangzixia novelonepotrapiddiagnostictechnologyforcovid19 AT houtieying novelonepotrapiddiagnostictechnologyforcovid19 AT lishan novelonepotrapiddiagnostictechnologyforcovid19 |